Processa Pharmaceuticals, Inc. (PCSA) — Dilution Risk Analysis

Current Snapshot

Processa Pharmaceuticals, Inc. (PCSA) has a DilutionWatch score of 65/10 and is classified as HIGH risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
2,793,386 Source
Public Float
2,477,548 Source
Float as % of Outstanding
88.7%

Dilution Risk Score

Score: 65/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

Recent filing forms in the source payload: FORM 4 9, 4 1.

FormFiledAccession
Form 4 2026-08-08 0000897069-26-001602|0001638744|2026-08-08|M|1600
4 2026-07-30 0001575202-26-000011
Form 4 2026-07-26 0000897069-26-001560|0001361896|2026-07-26|A|33500
Form 4 2026-07-26 0000897069-26-001558|0001308105|2026-07-26|A|11883
Form 4 2026-07-26 0000897069-26-001556|0001817209|2026-07-26|A|33500
Form 4 2026-07-26 0000897069-26-001554|0001638744|2026-07-26|A|9384
Form 4 2026-07-26 0000897069-26-001552|0001600865|2026-07-26|A|62221
Form 4 2026-07-26 0000897069-26-001550|0001799363|2026-07-26|A|8450
Form 4 2026-07-26 0000897069-26-001548|0001799360|2026-07-26|A|9450
Form 4 2026-07-26 0000897069-26-001546|0001686223|2026-07-26|A|33500

Dilution Risk Drivers

DriverStored ValueSource
Cash runway 0 months Source
Three-year share count growth 1714.51% Source

DilutionWatch Analysis

Risk Level
HIGH (Score: 65/10) Source
Cash Runway
0 months Source
Share Count Growth (3-Year)
1714.51% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.